Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non–Small Cell Lung Cancer in the US
2021 · JAMA Oncology · 714 citations
https://doi.org/10.1001/jamaoncol.2021.4932
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
31
Papers
1.6K
Citations
11
h-index
13
i10-index
Ion Cotarla is an academic researcher from AstraZeneca (Brazil). The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Diagnosis and Treatment & Cancer Immunotherapy and Biomarkers. The author has an h-index of 11, co-authored 27 publications.
ORCID: 0000-0002-8986-3616https://doi.org/10.1001/jamaoncol.2021.4932
https://doi.org/10.1186/1471-2407-8-21
Click to start Chat